News Overview

Patel Integrated Logistics Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.

Ajmera Realty & Infra India Limited has informed the Exchange about press release dated 19-May-2022 titled Promising performance with a robust launch pipeline, Achieves Revenue growth of 39% for FY22, YoY & 130% for Q4 FY22, YoY

Motherson Sumi Systems Limited has informed the Exchange about its Name Change to SAMVARDHANA MOTHERSON INTERNATIONAL LIMITED (SAMIL).

Zuari Agro Chemicals Limited has informed the Exchange about Closure of trading window

We inform you that the Board of Directors of the Company, at its meeting held today i.e. on 19th May, 2022, which commenced at 2.00 p.m. and concluded at 6.25 p.m. considered and approved, inter alia, the following items of business:1.Audited financial results, both standalone and consolidated, for the quarter and financial year ended 31st March, 2022. Pursuant to the Listing Regulations, we enclose the following:a)Audited financial results, both standalone and consolidated, for the quarter and financial year ended 31st March, 2022 (Financial Results);b)Auditors Report issued on the Financial Results;c)Declaration pursuant to Regulation 33(3)(d) of the Listing Regulations, regarding unmodified opinion of the Statutory Auditors on the Financial Results; andd)Press Release giving highlights of the Financial Results.2.Recommended dividend of Rs. 6.25 per equity share of face value of Rs. 10/- each (62.5%), for the financial year 2021-22. The dividend, if declared by the shareholders

Eros International Media Limited has informed the Exchange about resignation of Kishore Lulla as Executive Director of the company w.e.f. 19-May-2022

Tarmat Limited has informed the Exchange about press release dated 19-May-2022 titled Submission of News paper clippings

Rail Vikas Nigam Limited has informed the Exchange about Notice of Postal Ballot

Biocon Limited has informed the Exchange about press release dated 19-May-2022 titled Biocon Biologics and Viatris Launch Abevmy?? (bBevacizumab), Their Third Oncology Biosimilar, in Canada

Lincoln Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2022.